National Cancer Institute (NCI) shared on LinkedIn:
“Our Patient-Derived Models Repository (NCI-PDMR) recently released its first publicly available tissue microarray panel from patient-derived xenografts (PDX) of pancreatic adenocarcinoma. This new resource gives pancreatic cancer researchers a way to screen for protein biomarkers across 60 patient-derived tumor models on one slide – and access the models needed to investigate what they find.
The repository pairs tumor samples with genomic data and patient treatment histories. Researchers can then request the corresponding xenograft models, organoids or cell lines for follow-up studies. Explore what’s available and how the panel could support your research.”
You can also read: NCI Highlights Upcoming Virtual Events on Cancer Care, Research, and Prevention.